Acupuncture for CIPN in Breast Cancer Patients
Completed · Not applicable
Conditions studied: Sensation Disorders, Neuropathy
In brief
The aim of this study is to collect preliminary data on the effectiveness of acupuncture for the treatment of CIPN in breast cancer patients.
Key facts
- Study ID
- NCT02615678
- Run by
- Southern California University of Health Sciences
- People needed
- 10
- Starts
- 2015-10-01
- Expected to finish
- 2018-12-01
- Last updated by the study team
- 2019-05-16
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Minimum of 18 years of age
- Currently receiving neurotoxic chemotherapy
- Experiencing symptoms of chemotherapy induced neuropathy for at least 1 month
- Have a minimum score of 3 on the VAS should have a grade II CIPN on NCICTC
- Willing to sign an informed consent
- Stable treatment for more than two months before screening
- Stable treatment is defined as no change in the type and dose of medications 2 months prior to enrollment.
- Once enrolled, the patients will be asked to remain on the same type and dose of the medications for neuropathy
You may not qualify if…
- Receiving any treatment to prevent neuropathy 2 weeks prior to the screening
- Pre-existing peripheral neuropathy due to any other cause than chemotherapy
- Pre-existing conditions like pregnancy, uncontrolled diabetes, hypertension, cardiovascular disorders, bleeding disorders, depression (BDI > 21)
- Unwilling to follow the protocol
- Individuals who are receiving government disability assistance
Where it is running
- Southern California University of Health Sciences — Whittier, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.